Cancer Clinical Trial
Official title:
The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
Exposure to secondhand smoke is a leading preventable cause of child morbidity and
mortality, and the adverse health consequences of secondhand smoke are magnified among
youngsters with cancer and sickle cell disease. Current methods for measuring secondhand
smoke exposure (SHSe) rely on retrospective reports over extended time periods that are
subject to recall errors and systematic inaccuracies in reporting and often do not include
the youngster as the primary informant. These methods may underestimate the extent of
cumulative SHSe and are not well suited to capturing exposure over time and across settings
where young people frequent. More appealing methods that engage youngsters to better monitor
tobacco smoke in their environment are warranted.
The study will examine the feasibility of cell phone texting to obtain measures of
secondhand smoke exposure (SHSe) in children treated for cancer or sickle cell disease
(SCD).
Status | Completed |
Enrollment | 77 |
Est. completion date | November 2014 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 10 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Child Participant: - St. Jude Children's Research Hospital (SJCRH) patient with primary diagnosis of any type of cancer or any sickle cell disease genotype (HbSS, HbSC, HbSß°thal, HbSß+thal, HbSD, HbSO, Hb S/HPFH, HbSE). - 10 to < 18 years of age at the time of enrollment. - For cancer patients, at least one month from diagnosis and in active treatment section at the time of enrollment. - Lives in a smoking household defined as at least one adult (> 18 years) smoker who resides in the home. Smoking adults will be defined as those who have smoked at least one cigarette in the past 30 days, per parent report. - Does not currently use tobacco (defined as abstinence from tobacco during the 30 days preceding the screening assessment as based on patient and/or parent report). - Able to demonstrate satisfactory texting skills via mobile phone as determined by study research staff. - Cannot have significant cognitive or learning impairment that precludes completion of study measures. - Reads and speaks English. - Willing and able to provide assent according to institutional guidelines. - Parent Participant: - Parent of SJCRH patient who meets criteria as stated above. - Reads and speaks English. - Willing and able to provide informed consent according to institutional guidelines. Exclusion Criteria: - Child Participant: - Patients diagnosed with cancer who have relapsed or have recurrence of disease within the past month or those with progressive disease. - Patients in medical crisis as determined by consultation with their primary care physician. - On bone marrow transplant service. - On inpatient service or expected/scheduled inpatient admission (e.g. hospitalized). - Acute complications of sickle cell disease requiring hospitalization or an acute care visit including pain crises, acute chest syndrome, acute cerebrovascular events/stroke or active infection/fever. - Patient is residing in St. Jude long-term nonsmoking housing facility (e.g. Target House or Ronald McDonald House) during the 7-day texting data collection phase. - Parent participant: - Cannot be in crisis or distress or have another disabling condition that would preclude participation as determined by review of patient's medical record prior to study enrollment. |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | St. Jude Children's Research Hospital | Memphis | Tennessee |
Lead Sponsor | Collaborator |
---|---|
St. Jude Children's Research Hospital | San Diego State University, University of South Florida |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of participation and compliance by disease group | Rates of participation on the study, compliance with reporting SHSe, feedback about the technical viability of the texting methods, and satisfaction regarding the texting procedures will be obtained. | at end of 7-day period | No |
Secondary | Parent reports of child SHSe; attitudinal, behavioral, and other socio-environmental variables. | at end of 90-day period | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|